TRHC - Tabula Rasa HealthCare, Inc.
| Previous Close | 54.54 |
| Open | 54.58 |
| Bid | 56.93 x 1200 |
| Ask | 56.94 x 3100 |
| Day's Range | 54.14 - 57.35 |
| 52 Week Range | 40.86 - 83.37 |
| Volume | 392,213 |
| Avg. Volume | 325,107 |
| Market Cap | 1.257B |
| Beta (3Y Monthly) | 1.65 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.89 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 83.09 |
- Yahoo Finance Video
How tech is changing the health care industry
A new ETF is setting its sights on advancing the field of health care technology. ROBO Global Healthcare Technology and Innovation ETF is giving investors another option to capture innovation and growth within the space. Travis Briggs, ROBO Global CEO, discusses with Yahoo Finance's Akiko Fujita on "The Ticker."
- GlobeNewswire
Tabula Rasa HealthCare’s DoseMe® Bayesian Forecasting Method Receives Rating of Most User-Friendly in Clinical Study
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, announced an independent study evaluating Bayesian Forecasting (BF) programs found TRHC’s DoseMe BF program, DoseMeRx, to be the most user-friendly. BF programs, such as DoseMeRx, use patient data and laboratory results to estimate a patient’s ability to process a drug.
- GlobeNewswire
Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced pharmacy executive Dr Kristi Kuper joins subsidiary DoseMe as Director of Clinical Pharmacy. Dr. Kuper is a Board Certified Pharmacotherapy Specialist who has spent the last 20 years in a variety of clinical pharmacy leadership roles working with more than 500 hospitals.
- GlobeNewswire
TRHC and Troy Medicare Leverage Technology to Provide Innovative Care Coordination
MOORESTOWN, N.J. and CHARLOTTE, N.C., Sept. 10, 2019 -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ:TRHC), a leading provider of technology-enabled solutions to mitigate.
- Simply Wall St.
Would Tabula Rasa HealthCare (NASDAQ:TRHC) Might Be Better Off With Less Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- GlobeNewswire
Tabula Rasa HealthCare Expands Services to PACE in Louisiana
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, has been selected by PACE of Greater New Orleans (PACE GNO) to provide medication risk mitigation and comprehensive pharmacy services for the second PACE program in Louisiana. Services will began September 1, 2019.
- GlobeNewswire
Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences
MOORESTOWN, N.J., Aug. 28, 2019 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today.
- Zacks
Tabula Rasa HealthCare, Simpson Manufacturing, Verizon Communications, Coca-Cola and Jack in the Box highlighted as Zacks Bull and Bear of the Day
Tabula Rasa HealthCare, Simpson Manufacturing, Verizon Communications, Coca-Cola and Jack in the Box highlighted as Zacks Bull and Bear of the Day
- GlobeNewswire
Bainbridge Health Partners with Tabula Rasa HealthCare’s subsidiary DoseMe To Expand Medication Management Capabilities to Health System(s)
Tabula Rasa HealthCare, Inc (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced a partnership between its precision dosing software subsidiary DoseMe and Bainbridge Health, a Children’s Hospital of Philadelphia (CHOP) spin-off. “Managing medications to prevent patient harm and to reduce waste is an incredibly complex and challenging process for hospital clinicians,” said Joseph Kaupp, Co-founder and CEO of Bainbridge Health. Bainbridge Health provides clinical solutions based on more than a decade of research and development, including the Med O.S® medication safety and stewardship platform that reduces the risk of medication errors and waste.
- GuruFocus.com
Tabula Rasa Healthcare Inc (TRHC) CEO Calvin H Knowlton Sold $513,040 of Shares
CEO of Tabula Rasa Healthcare Inc (30-Year Financial, Insider Trades) Calvin H Knowlton (insider trades) sold 8,000 shares of TRHC on 08/19/2019 at an average price of $64.13 a share. Continue reading...
- GlobeNewswire
TRHC to Provide Comprehensive Medication Review Opportunities to Community Pharmacists
Tabula Rasa HealthCare (TRHC) a leading provider of technology-enabled solutions to mitigate medication risk and reduce medical costs, today announced a new offering of Comprehensive Medication Review (CMR) opportunities to community pharmacists through the collaboration of two of its subsidiary companies, SinfoníaRx (SRx) and PrescribeWellness (PW). Community pharmacists now will have the opportunity to conduct face-to-face CMRs with their patients and receive compensation for additional clinical services. “Engaging community pharmacists to provide in-person CMRs through PW’s Patient Engagement Center enhances our current solution and will further our efforts to expand community pharmacy practice,” explained TRHC Chairman and CEO Calvin H. Knowlton, PhD.
Motley FoolTabula Rasa HealthCare, Inc. Common Stock (TRHC) Q2 2019 Earnings Call Transcript
TRHC earnings call for the period ending June 30, 2019.
- Zacks
Tabula Rasa Healthcare (TRHC) Surpasses Q2 Earnings and Revenue Estimates
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 600.00% and 8.69%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Tabula Rasa HealthCare Announces Second Quarter 2019 Operating Results
MOORESTOWN, N.J., Aug. 08, 2019 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today.
- Simply Wall St.
How Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Can Impact Your Portfolio Volatility
Anyone researching Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) might want to consider the historical volatility of the...
- GuruFocus.com
Tabula Rasa Healthcare Inc (TRHC) CFO Brian W Adams Sold $600,000 of Shares
CFO of Tabula Rasa Healthcare Inc (30-Year Financial, Insider Trades) Brian W Adams (insider trades) sold 10,000 shares of TRHC on 07/31/2019 at an average price of $60 a share. Continue reading...
- Zacks
Analysts Estimate Tabula Rasa Healthcare (TRHC) to Report a Decline in Earnings: What to Look Out for
Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
Tabula Rasa HealthCare Executive to Present at EXPO.health 2019
Tabula Rasa HealthCare (TRHC), a healthcare technology company advancing the field of medication safety, today announced Senior Vice President for Healthcare Analytics Alan Stein, MD, PhD, will present on the topic of data science at the EXPO.health 2019 conference to be held July 31-August 2 in Boston, Mass.
- GlobeNewswire
Tabula Rasa Healthcare to Announce Second Quarter 2019 Operating Results and Host Conference Call on Thursday, August 8, 2019
MOORESTOWN, N.J., July 23, 2019 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its second.
- Zacks
NXGN or TRHC: Which Is the Better Value Stock Right Now?
NXGN vs. TRHC: Which Stock Is the Better Value Option?
- GlobeNewswire
TRHC and CQuentia Announce Collaboration to Leverage Scientific and Technology Resources to Provide Pharmacogenomic Services and Biometric Wearable Products to Patients and Providers
Tabula Rasa HealthCare, Inc. (“TRHC”) (TRHC), a leading provider of technology-enabled solutions to mitigate medication risk, reduce medical costs, and optimize client performance, today announced it has signed two agreements to collaborate with CQuentia. CQuentia is a comprehensive analytics platform for personalized medicine, integrating genetic test results with scientific and clinical action. The collaboration will bring a robust suite of cutting-edge pharmacogenomics services and biometric wearable products to patients and providers. “CQuentia has selected TRHC’s MedWise™ as its preferred method for delivering pharmacogenomics (PGx) lab results back to ordering physicians,” said CQuentia CEO Alan Meeker.
